Sunshine Biopharma Inc (SBFM)

[Learjetter]

Page 12 of the pathetic S1 filing....

We are a development stage company and may never attain product sales. I can copy and paste too....all from their filings. Actual status, not hopes like others post....

 We have not received approval for any of our product candidates from the FDA.  Any compounds that we discover or in-license will require extensive and costly development, preclinical testing and/or clinical trials prior to seeking regulatory approval for commercial sales.  Our most advanced and only product candidate, Adva-27a, may never be approved for commercial sale.  The time required to attain product sales and profitability is lengthy and highly uncertain, and we cannot assure you that we will be able to achieve product sales.

12

 We expect our net operating losses to continue for at least several years, and we are unable to predict the extent of future losses or when we will become profitable, if ever.  We have incurred significant net losses since our formation in 2009.  We have incurred an accumulated deficit of $13,618,190 as of December 31, 2017 and $14,528,134 as of June 30, 2018.  Our operating losses are due in large part to the significant research and development costs required to identify, validate and license potential product candidates, conduct preclinical studies and conduct clinical trials of our more advanced product candidates.  To date, we have not generated any revenues from product sales and we do not anticipate generating any sales revenues in the near term, if ever.  We expect to increase our operating expenses over the next several years as we plan to: